| Literature DB >> 33909457 |
Alexandr A Kalinin1,2,3, Xinhai Hou1,4,2, Alex S Ade2, Gordon-Victor Fon2, Walter Meixner2, Gerald A Higgins2, Jonathan Z Sexton5,6,7, Xiang Wan1, Ivo D Dinov2,3,8, Matthew J O'Meara2, Brian D Athey2,8,9.
Abstract
Histone deacetylase inhibitors, such as valproic acid (VPA), have important clinical therapeutic and cellular reprogramming applications. They induce chromatin reorganization that is associated with altered cellular morphology. However, there is a lack of comprehensive characterization of VPA-induced changes of nuclear size and shape. Here, we quantify 3D nuclear morphology of primary human astrocyte cells treated with VPA over time (hence, 4D). We compared volumetric and surface-based representations and identified seven features that jointly discriminate between normal and treated cells with 85% accuracy on day 7. From day 3, treated nuclei were more elongated and flattened and then continued to morphologically diverge from controls over time, becoming larger and more irregular. On day 7, most of the size and shape descriptors demonstrated significant differences between treated and untreated cells, including a 24% increase in volume and 6% reduction in extent (shape regularity) for treated nuclei. Overall, we show that 4D morphometry can capture how chromatin reorganization modulates the size and shape of the nucleus over time. These nuclear structural alterations may serve as a biomarker for histone (de-)acetylation events and provide insights into mechanisms of astrocytes-to-neurons reprogramming.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33909457 PMCID: PMC8684733 DOI: 10.1091/mbc.E20-08-0502
Source DB: PubMed Journal: Mol Biol Cell ISSN: 1059-1524 Impact factor: 4.138
FIGURE 1:A schematic overview of the experiment, data collection, and analysis. (A) Sample preparation, treatment, and imaging. (B) 3D nuclear segmentation, shape modeling, and feature extraction. (C) Feature selection, and univariate statistical and machine learning analysis.
Number of segmented astrocyte nuclear 3D binary masks per day for each treatment condition after QC (number of nuclei filtered by quality control is in parentheses).
| Day | |||
|---|---|---|---|
| Treatment | 3 | 5 | 7 |
| NHA | 186 (−23) | 163 (−18) | 101 (−10) |
| VPA | 128 (−18) | 67 (−6) | 78 (−15) |
| Total | 314 (−41) | 230 (−24) | 179 (−35) |
FIGURE 2:Morphological classification performance. (A) hierarchical clustering of the Pearson correlations among all voxel and surface features (V + S), showing representative size and shape descriptors. (B) 2D t-distributed stochastic neighbor embedding (t-SNE) of the selected feature space, showing corresponding conditions (NHA or VPA) at every time point (day 3, 5, or 7). The lines denote clusters identified by kernel density estimation. (C) Receiver operating characteristic (ROC) curves for the SVM classifier with S7 features on days 3, 5, and 7. (D) Average normalized confusion matrices for the SVM classifier on the S7 features. (E) SVM-estimated permutation importance of S7 features for distinguishing nuclear morphologies on each day.
FIGURE 3:Visualization and univariate statistical analysis of size changes under VPA treatment. (A) Reconstructed surfaces of representative NHA and VPA nuclei on days 3, 5, and 7. (B) Time-dependent changes in morphometric measures of nuclear sizes (points show mean; error bars show SD; *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001).
FIGURE 4:Visualization and univariate statistical analysis of shape changes under VPA treatment. (A) Reconstructed surfaces of a representative NHA and VPA nuclei on days 5 and 7, annotated with per-vertex mean curvature. (B) Time-dependent changes in morphometric measures of nuclear shapes (points show mean; error bars show SD; *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001). (C) XY maximum intensity projections of VPA-treated nuclei with irregular shapes and blebbing.